Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib Era
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology
Link
http://link.springer.com/article/10.1007/s12288-018-1009-y/fulltext.html
Reference22 articles.
1. Ganesan P, Kumar L (2017) Chronic myeloid leukemia in India. J Glob Oncol 3(1):64–71
2. Goldman JM (2013) Chronic myeloid leukemia in India. Indian J Med Paediatr Oncol 34(3):147–148
3. Glivec® International Patient Assistance Program (GIPAP). http://www.themaxfoundation.org/gipap/Default.aspx . Accessed 31 Mar 2018
4. Castagnetti F, Gugliotta G, Breccia M, Stagno F, Iurlo A, Albano F et al (2015) Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib. Leukemia 29(9):1823–1831
5. Bower H, Björkholm M, Dickman PW, Höglund M, Lambert PC, Andersson TM (2016) Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population. J Clin Oncol 34(24):2851–2857
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Outcomes of Allogeneic Stem Cell Transplant in Chronic Myeloid Leukemia - Blast Phase: A Single-center Experience from South India;Indian Journal of Medical and Paediatric Oncology;2022-11-28
2. A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase;Journal of Hematology & Oncology;2022-07-11
3. Turkey real-life data: demographic features, treatment results and effects of comorbidities in chronic myeloid leukemia;International Journal of Hematologic Oncology;2022-06
4. Association between adherence to oral therapies in cancer patients and clinical outcome: A systematic review of the literature;British Journal of Clinical Pharmacology;2021-12-23
5. Long-Term Outcome of Philadelphia Chromosome Positive Leukemia From Eastern Indian Subcontinent: An Experience in the Era of Tyrosine Kinase Inhibitor (TKI) Therapy;Clinical Lymphoma Myeloma and Leukemia;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3